GB0600749D0 - Pharmaceutically acceptable co-crystalline forms - Google Patents

Pharmaceutically acceptable co-crystalline forms

Info

Publication number
GB0600749D0
GB0600749D0 GBGB0600749.6A GB0600749A GB0600749D0 GB 0600749 D0 GB0600749 D0 GB 0600749D0 GB 0600749 A GB0600749 A GB 0600749A GB 0600749 D0 GB0600749 D0 GB 0600749D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutically acceptable
crystalline forms
crystalline
forms
pharmaceutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0600749.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pliva Hrvatska doo
Original Assignee
Pliva Hrvatska doo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Hrvatska doo filed Critical Pliva Hrvatska doo
Priority to GBGB0600749.6A priority Critical patent/GB0600749D0/en
Publication of GB0600749D0 publication Critical patent/GB0600749D0/en
Priority to PCT/GB2006/004150 priority patent/WO2007080362A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
GBGB0600749.6A 2006-01-14 2006-01-14 Pharmaceutically acceptable co-crystalline forms Ceased GB0600749D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0600749.6A GB0600749D0 (en) 2006-01-14 2006-01-14 Pharmaceutically acceptable co-crystalline forms
PCT/GB2006/004150 WO2007080362A1 (en) 2006-01-14 2006-11-06 Pharmaceutically acceptable co-crystalline forms of sildenafil

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0600749.6A GB0600749D0 (en) 2006-01-14 2006-01-14 Pharmaceutically acceptable co-crystalline forms

Publications (1)

Publication Number Publication Date
GB0600749D0 true GB0600749D0 (en) 2006-02-22

Family

ID=35998051

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0600749.6A Ceased GB0600749D0 (en) 2006-01-14 2006-01-14 Pharmaceutically acceptable co-crystalline forms

Country Status (2)

Country Link
GB (1) GB0600749D0 (en)
WO (1) WO2007080362A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009012923A1 (en) * 2007-07-26 2009-01-29 F. Hoffmann-La Roche Ag Dissolution apparatus
CN101424608B (en) * 2007-10-31 2011-04-20 比亚迪股份有限公司 Co3O4 and CoO content analytical method in lithium cobalt oxide
CA2802047C (en) * 2010-06-07 2019-05-07 Novadel Pharma Inc. Oral spray formulations and methods for administration of sildenafil
CN104940154A (en) * 2015-07-23 2015-09-30 青岛蓝盛洋医药生物科技有限责任公司 Sildenafil citrate composition tablet as medicine for treating urological diseases
CN104940166A (en) * 2015-07-23 2015-09-30 青岛蓝盛洋医药生物科技有限责任公司 Sildenafil citrate composition capsule as medicine for treating male impotence
CN104997754A (en) * 2015-08-05 2015-10-28 青岛蓝盛洋医药生物科技有限责任公司 Analgesic-antipyretic aspirin composition capsule
CN105106134A (en) * 2015-09-23 2015-12-02 青岛华之草医药科技有限公司 Composition granules of antipyretic analgesic anti-inflammatory medicine aspirin
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil

Also Published As

Publication number Publication date
WO2007080362A1 (en) 2007-07-19

Similar Documents

Publication Publication Date Title
EP1992348A4 (en) Pharmaceutical combination
EP2098250A4 (en) Orally disintegrating solid preparation
ME01580B (en) Pharmaceutical dosage forms
HK1125295A1 (en) Microtablet-based pharmaceutical preparation
EP2050882A4 (en) Toilet
ZA200806318B (en) Drug combinations
GB0600749D0 (en) Pharmaceutically acceptable co-crystalline forms
GB0606234D0 (en) Pharmaceutically acceptable salts and polymorphic forms
IL197883A0 (en) Combination drug
GB0625783D0 (en) Medicament
GB0613928D0 (en) Pharmaceutically acceptable salt and polymorphic forms
GB0612063D0 (en) Railing
ZA200903523B (en) Poly-TLR antagonist
GB0615064D0 (en) Medicament
GB0703118D0 (en) Toilet
GB0605344D0 (en) Pharmaceutically acceptable salts and polymorphic forms
GB2435041A9 (en) Sillicon-containing benzophenone derivatives
GB0615814D0 (en) Medicament
GB0609465D0 (en) Pharmaceutically acceptable salts and polymorphic forms
ZA200708369B (en) Medicament
GB0614457D0 (en) Pharmaceutical Combinations
GB0625433D0 (en) Pharmaceutical combinations
GB0613927D0 (en) Pharmaceutically acceptable salt and polymorphic forms
ZA200902756B (en) Combination drug
AU309434S (en) Toilet

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)